Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP482663.RAP5RBKzObBMQyWYWNeXV782NWaPnF5iiVTiP88H1OZAg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP482663.RAP5RBKzObBMQyWYWNeXV782NWaPnF5iiVTiP88H1OZAg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP482663.RAP5RBKzObBMQyWYWNeXV782NWaPnF5iiVTiP88H1OZAg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP482663.RAP5RBKzObBMQyWYWNeXV782NWaPnF5iiVTiP88H1OZAg130_provenance.
- NP482663.RAP5RBKzObBMQyWYWNeXV782NWaPnF5iiVTiP88H1OZAg130_assertion description "[Similarly, there were no increased risks associated with the XRCC2 GA/AA genotype (OR, 0.98; 95% CI, 0.76-1.26 for breast cancer and OR, 0.93; 95% CI, 0.69-1.25 for ovarian cancer) or the XRCC3 CT/TT genotype (OR, 0.92; 95% CI, 0.77-1.10 for breast cancer and OR, 0.87; 95% CI, 0.71-1.08 for ovarian cancer).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482663.RAP5RBKzObBMQyWYWNeXV782NWaPnF5iiVTiP88H1OZAg130_provenance.
- NP482663.RAP5RBKzObBMQyWYWNeXV782NWaPnF5iiVTiP88H1OZAg130_assertion evidence source_evidence_literature NP482663.RAP5RBKzObBMQyWYWNeXV782NWaPnF5iiVTiP88H1OZAg130_provenance.
- NP482663.RAP5RBKzObBMQyWYWNeXV782NWaPnF5iiVTiP88H1OZAg130_assertion SIO_000772 15734952 NP482663.RAP5RBKzObBMQyWYWNeXV782NWaPnF5iiVTiP88H1OZAg130_provenance.
- NP482663.RAP5RBKzObBMQyWYWNeXV782NWaPnF5iiVTiP88H1OZAg130_assertion wasDerivedFrom befree-2016 NP482663.RAP5RBKzObBMQyWYWNeXV782NWaPnF5iiVTiP88H1OZAg130_provenance.
- NP482663.RAP5RBKzObBMQyWYWNeXV782NWaPnF5iiVTiP88H1OZAg130_assertion wasGeneratedBy ECO_0000203 NP482663.RAP5RBKzObBMQyWYWNeXV782NWaPnF5iiVTiP88H1OZAg130_provenance.
- befree-2016 importedOn "2016-02-19" NP482663.RAP5RBKzObBMQyWYWNeXV782NWaPnF5iiVTiP88H1OZAg130_provenance.